Sg3 Management, LLC Intellia Therapeutics, Inc. Transaction History

Sg3 Management, LLC

  • $0
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$100.76 - $138.36 $1.31 Million - $1.8 Million
-13,000 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$132.37 - $176.78 $1.59 Million - $2.12 Million
-12,000 Reduced 48.0%
13,000 $1.74 Million
Q2 2021

Aug 16, 2021
BUY
$60.88 - $161.91 $913,200 - $2.43 Million
15,000 Added 150.0%
25,000 $4.05 Million
Q1 2021

May 17, 2021
BUY
$46.59 - $83.68 $465,900 - $836,800
10,000 New
10,000 $803,000

Others Institutions Holding NTLA

# of Institutions
315
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.16B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email